Changes related to "Pegylated liposomal doxorubicin (Doxil)"
This is a list of changes made recently to pages linked from a specified page (or to members of a specified category). Pages on your watchlist are bold.
19 September 2018
| m 22:17 | Ovarian cancer (4 changes | history) . . (+4,865) . . [Jwarner (4×)] | |
| m | 22:17 (cur | prev) . . (+1,552) . . Jwarner (talk | contribs) (→Cisplatin & Cyclophosphamide {{#subobject:d427c4|Regimen=1}}) | |
| m | 20:00 (cur | prev) . . (+1,262) . . Jwarner (talk | contribs) (→Cisplatin & Cyclophosphamide {{#subobject:d427c4|Regimen=1}}) | |
| m | 19:47 (cur | prev) . . (+1,337) . . Jwarner (talk | contribs) (→Cisplatin & Cyclophosphamide {{#subobject:d427c4|Regimen=1}}) | |
| m | 19:39 (cur | prev) . . (+714) . . Jwarner (talk | contribs) (→Cisplatin & Paclitaxel {{#subobject:d05939|Regimen=1}}) |
18 September 2018
| m 19:42 | Ovarian cancer (diff | hist) . . (+1,947) . . Jwarner (talk | contribs) (→First-line chemotherapy for advanced/metastatic disease) |
| m 11:10 | Hodgkin lymphoma (diff | hist) . . (+900) . . Jwarner (talk | contribs) |
17 September 2018
| m 22:14 | Diffuse large B-cell lymphoma (diff | hist) . . (+4) . . Warner-admin (talk | contribs) (Text replacement - "'''Subset analysis:'''" to "'''Subgroup analysis:'''") |
| m 22:11 | Ovarian cancer (diff | hist) . . (+1,359) . . Jwarner (talk | contribs) (→Carboplatin & Docetaxel {{#subobject:8cd1bc|Regimen=1}}) |
| 21:49 | Hodgkin lymphoma (diff | hist) . . (+3,047) . . Jwarner (talk | contribs) |
16 September 2018
| m 21:43 | Hodgkin lymphoma (2 changes | history) . . (+687) . . [Jwarner (2×)] | |
| m | 21:43 (cur | prev) . . (+1,953) . . Jwarner (talk | contribs) (→CBV, then auto HSCT {{#subobject:935235|Regimen=1}}) | |
| m | 21:37 (cur | prev) . . (-1,266) . . Jwarner (talk | contribs) (→BEAM, then auto HSCT {{#subobject:ed61ad|Regimen=1}}) |
| m 12:40 | Breast cancer (diff | hist) . . (+1,267) . . Jwarner (talk | contribs) (→Variant #16, 1200/50/1200 x 6 {{#subobject:d46835|Variant=1}}) |
15 September 2018
| m 22:47 | Hodgkin lymphoma (2 changes | history) . . (-407) . . [Jwarner (2×)] | |
| m | 22:47 (cur | prev) . . (-423) . . Jwarner (talk | contribs) (→References) | |
| m | 22:40 (cur | prev) . . (+16) . . Jwarner (talk | contribs) (→References) |
14 September 2018
| m 11:31 | Hodgkin lymphoma (5 changes | history) . . (+2,435) . . [Jwarner (5×)] | |
| m | 11:31 (cur | prev) . . (+29) . . Jwarner (talk | contribs) (→Investigational agents) | |
| m | 11:22 (cur | prev) . . (+471) . . Jwarner (talk | contribs) (→Brentuximab vedotin monotherapy {{#subobject:c7e71|Regimen=1}}) | |
| m | 11:18 (cur | prev) . . (+1,332) . . Jwarner (talk | contribs) | |
| m | 11:08 (cur | prev) . . (+572) . . Jwarner (talk | contribs) | |
| m | 11:04 (cur | prev) . . (+31) . . Jwarner (talk | contribs) |
| m 09:54 | Bortezomib (Velcade) (2 changes | history) . . (+469) . . [Jwarner (2×)] | |
| m | 09:54 (cur | prev) . . (0) . . Jwarner (talk | contribs) | |
| m | 09:54 (cur | prev) . . (+469) . . Jwarner (talk | contribs) (→Notable side effects) |
13 September 2018
| m 17:53 | Breast cancer (diff | hist) . . (+689) . . Jwarner (talk | contribs) (→CMFT {{#subobject:acff18|Regimen=1}}) |
12 September 2018
| m 22:39 | Hodgkin lymphoma (3 changes | history) . . (+6,717) . . [Jwarner (3×)] | |
| m | 22:39 (cur | prev) . . (+30) . . Jwarner (talk | contribs) | |
| m | 22:36 (cur | prev) . . (+5,526) . . Jwarner (talk | contribs) | |
| m | 21:13 (cur | prev) . . (+1,161) . . Jwarner (talk | contribs) (→ABVD {{#subobject:3065be|Regimen=1}}) |
| m 22:12 | Diffuse large B-cell lymphoma (diff | hist) . . (+45) . . Jwarner (talk | contribs) |
